Limpar
4 resultados

Acesso aberto

Tipo do recurso

Ano de criação

Produção nacional

Revisado por pares

Áreas

Idioma

Editores

Artigo Acesso aberto Revisado por pares

Sara Ronchi, A. Cicchetti, Maria Bonora, Rossana Ingargiola, Anna Maria Camarda, Stefania Russo, Sara Imparato, Paolo Castelnuovo, Ernesto Pasquini, Piero Nicolai, Mohssen Ansarin, Michele Del Vecchio, Marco Benazzo, Ester Orlandi, Barbara Vischioni,

To evaluate efficacy and toxicity of carbon ion radiotherapy (CIRT) in locally advanced head and neck mucosal melanoma (HNMM) patients treated at our Institute.

Tópico(s): Cutaneous Melanoma Detection and Management

2023 - Elsevier BV | Radiotherapy and Oncology

Artigo Acesso aberto

Cleo Study Group, Antonio Ascione, Luigi Elio Adinolfi, Pietro Amoroso, Angelo Andriulli, Orlando Armignacco, Tiziana Ascione, Sergio Babudieri, Giorgio Barbarini, Michele Brogna, Francesco Cesario, Vincenzo Citro, Ernesto Claar, Raffaele Cozzolongo, Giuseppe D’Adamo, E D'Amico, Pellegrino Dattolo, M. De Luca, Vincenzo De Maria, Massimo De Siena, Giuseppe De Vita, Antonio Di Giacomo, Rosanna De Marco, G. de Stefano, Giulio De Stefano, Sebastiano Di Salvo, Raffaele Di Sarno, Nunzia Farella, L Felicioni, Basilio Fimiani, Luca Fontanella, Giuseppe Foti, Caterina Furlan, Francesca R. Giancotti, Giancarlo Giolitto, Tiziana Gravina, Barbara Guerrera, Roberto Gulminetti, A. Iacobellis, Michele Imparato, Angelo Iodice, Vincenzo Iovinella, Antonio Izzi, A. Liberti, Pietro Leo, Gennaro Lettieri, Ileana Luppino, Aldo Marrone, Ettore Mazzoni, Vincenzo Messina, Roberto Monarca, Vincenzo Narciso, L. Nosotti, Adriano Pellicelli, Alessandro Perrella, G. Piai, Antonio Picardi, Paola Pierri, Grazia Pietromatera, Francesco Resta, Luca Rinaldi, Mario Romano, Angelo Rossini, Maurizio Russello, Grazia Russo, Rodolfo Sacco, Vincenzo Sangiovanni, A Schiano, Antonio Sciambra, Gaetano Scifo, Filomena Simeone, Annarita Sullo, Pierluigi Tarquini, Paolo Tundo, Alfredo Vallone,

To check the safety and efficacy of boceprevir/telaprevir with peginterferon/ribavirin for hepatitis C virus (HCV) genotype 1 in the real-world settings.This study was a non-randomized, observational, prospective, multicenter. This study involved 47 centers in Italy. A database was prepared for the homogenous collection of the data, was used by all of the centers for data collection, and was updated continuously. All of the patients enrolled in this study were older than 18 years of age and were ...

Tópico(s): HIV/AIDS drug development and treatment

2016 - Baishideng Publishing Group | World Journal of Hepatology

Artigo Revisado por pares

Luca Rinaldi, Vincenzo Messina, V. Di Marco, Vincenzo Iovinella, Ernesto Claar, Giuseppe Cariti, Rodolfo Sacco, M. De Luca, Gaetano Scifo, Pietro Gatti, Giorgio Barbarini, Valeria Pace Palitti, Mariano Quartini, Paolo Tundo, Gianpiero D’Offizi, Giustino Parruti, Maria Antonietta Di Rosolini, Giovanni Garrucciu, Lucio Cosco, F. Benanti, Giancarlo Gimignani, Umberto Vespasiani‐Gentilucci, Francesco Di Lorenzo, Maria D’Antò, Riccardo Nevola, Tommaso Lupia, Valerio Rosato, Valeria Morbiducci, Ilaria Luzzitelli, Federica Sozio, Marco Di Stefano, Emanuela Ciracì, Fabio Bulla, Riccardo Guarisco, Cecilia Cangiano, Michele Imparato, Paolo Maggi, Antonio Ascione, Antonio Craxı̀, Antonio Izzi,

INTRODUCTION: We assessed the performance of direct-acting antivirals (DAAs) in hepatitis C virus (HCV)-infected people who use drugs (PWUDs) in terms of sustained virological response (SVR) and adherence rates in comparison to a location-matched cohort of non-PWUD HCV patients. METHODS: All consecutive HCV RNA-positive PWUDs were enrolled between 2015 and 2019. All subjects underwent DAA treatment according to international guidelines and then followed, at least, up to 12 weeks after the end of treatment ( ...

Tópico(s): Liver Disease Diagnosis and Treatment

2021 - Lippincott Williams & Wilkins | The American Journal of Gastroenterology